On February 28, 2022, the Patent Trial and Appeal Board (PTAB) issued a decision in Interference No. 106,115, which granted
Continue Reading PTAB Sides with Broad in Patent Dispute over CRISPR Gene Editing of Eukaryotic Cells

On February 28, 2022, the Patent Trial and Appeal Board (PTAB) issued a decision in Interference No. 106,115, which granted…
Continue Reading PTAB Sides with Broad in Patent Dispute over CRISPR Gene Editing of Eukaryotic Cells
Vertex Pharmaceuticals and Mammoth Biosciences, a Brisbane, California-based genetic research company, announced a new collaboration for the development of in …
Continue Reading Vertex and Mammoth Biosciences Ink $700M Deal for Ultra-Small CRISPR Systems
Following the successful development (and financial success) of its mRNA vaccine, biotech company Moderna is now looking to expand into…
Continue Reading Moderna’s Next Steps: Spikevax Today, Gene Editing Tomorrow
We use cookies to enhance your user experience. By continuing to use this site you are giving your consent for us to use cookies. For more information, please see our Privacy Policy.